To further confirm that YWHAH promotes gastric cancer cells proliferation by activating the PI3K/AKT/mTOR signaling pathway, we used rapamycin, an inhibitor of the PI3K/AKT/mTOR signaling pathway to treat gastric cancer cells. This evidence concerns the gene AKT1 and gastric cancer.